Nanobiotix (NASDAQ:NBTX) Shares Gap Up – What’s Next?

Nanobiotix S.A. – Sponsored ADR (NASDAQ:NBTX)’s share price gapped up prior to trading on Tuesday. The stock had previously closed at $31.53, but opened at $33.13. Nanobiotix shares last traded at $32.5090, with a volume of 14,517 shares trading hands.

Analysts Set New Price Targets

A number of analysts have recently commented on the company. Weiss Ratings reissued a “sell (d-)” rating on shares of Nanobiotix in a research note on Thursday, October 15th. Guggenheim assumed coverage on Nanobiotix in a research note on Tuesday, September 15th. They issued a “buy” rating and a $64.00 price objective for the company. Four investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Nanobiotix has an average rating of “Moderate Buy” and an average price target of $46.67.

Nanobiotix Price Performance

The business has a 50-day simple moving average of $33.30 and a 200 day simple moving average of $33.47.

About Nanobiotix

Nanobiotix is a biotechnology company developing nanoparticle-based therapies designed to improve the effectiveness of radiotherapy in cancer treatment. The company’s technology uses hafnium oxide nanoparticles that are injected directly into a tumor and activated by ionizing radiation, with the goal of increasing energy deposition within cancer cells while limiting exposure to surrounding tissue.

Nanobiotix’s lead product candidate, NBTXR3, is being evaluated in clinical studies across several cancer types, including locally advanced head and neck cancer and other solid tumors.